-+ 0.00%
-+ 0.00%
-+ 0.00%

CVS Health Sees FY2026 Adj EPS $7.00-$7.20 vs $7.18 Est; Sees Sales Of At Least $400B vs $409.911B Est

Benzinga·12/09/2025 11:42:49
Listen to the news

2026 full-year financial guidance

The Company is initiating its 2026 full-year financial guidance as follows:

  • Total revenues of at least $400.0 billion
  • GAAP operating income guidance range of $13.26 billion to $13.60 billion
  • Adjusted operating income guidance range of $15.07 billion to $15.41 billion
  • GAAP diluted EPS guidance range of $5.94 to $6.14
  • Adjusted EPS guidance range of $7.00 to $7.20
  • Cash flow from operations guidance of at least $10.0 billion